These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 11932067)

  • 1. Analgesic and anti-inflammatory effects of A-286501, a novel orally active adenosine kinase inhibitor.
    Jarvis MF; Yu H; McGaraughty S; Wismer CT; Mikusa J; Zhu C; Chu K; Kohlhaas K; Cowart M; Lee CH; Stewart AO; Cox BF; Polakowski J; Kowaluk EA
    Pain; 2002 Mar; 96(1-2):107-18. PubMed ID: 11932067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ABT-702 (4-amino-5-(3-bromophenyl)-7-(6-morpholino-pyridin- 3-yl)pyrido[2,3-d]pyrimidine), a novel orally effective adenosine kinase inhibitor with analgesic and anti-inflammatory properties. II. In vivo characterization in the rat.
    Kowaluk EA; Mikusa J; Wismer CT; Zhu CZ; Schweitzer E; Lynch JJ; Lee CH; Jiang M; Bhagwat SS; Gomtsyan A; McKie J; Cox BF; Polakowski J; Reinhart G; Williams M; Jarvis MF
    J Pharmacol Exp Ther; 2000 Dec; 295(3):1165-74. PubMed ID: 11082454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ABT-702 (4-amino-5-(3-bromophenyl)-7-(6-morpholinopyridin-3-yl)pyrido[2, 3-d]pyrimidine), a novel orally effective adenosine kinase inhibitor with analgesic and anti-inflammatory properties: I. In vitro characterization and acute antinociceptive effects in the mouse.
    Jarvis MF; Yu H; Kohlhaas K; Alexander K; Lee CH; Jiang M; Bhagwat SS; Williams M; Kowaluk EA
    J Pharmacol Exp Ther; 2000 Dec; 295(3):1156-64. PubMed ID: 11082453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the effects of adenosine kinase inhibitors on acute thermal nociception in mice.
    Kowaluk EA; Kohlhaas KL; Bannon A; Gunther K; Lynch JJ; Jarvis MF
    Pharmacol Biochem Behav; 1999 May; 63(1):83-91. PubMed ID: 10340527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the ability of adenosine kinase inhibitors and adenosine receptor agonists to attenuate thermal hyperalgesia and reduce motor performance in rats.
    Jarvis MF; Mikusa J; Chu KL; Wismer CT; Honore P; Kowaluk EA; McGaraughty S
    Pharmacol Biochem Behav; 2002 Oct; 73(3):573-81. PubMed ID: 12151032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A-134974: a novel adenosine kinase inhibitor, relieves tactile allodynia via spinal sites of action in peripheral nerve injured rats.
    Zhu CZ; Mikusa J; Chu KL; Cowart M; Kowaluk EA; Jarvis MF; McGaraughty S
    Brain Res; 2001 Jun; 905(1-2):104-10. PubMed ID: 11423084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antinociceptive and anti-inflammatory properties of an adenosine kinase inhibitor and an adenosine deaminase inhibitor.
    Poon A; Sawynok J
    Eur J Pharmacol; 1999 Nov; 384(2-3):123-38. PubMed ID: 10611432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of ABT-702, a novel adenosine kinase inhibitor, on the responses of spinal neurones following carrageenan inflammation and peripheral nerve injury.
    Suzuki R; Stanfa LC; Kowaluk EA; Williams M; Jarvis MF; Dickenson AH
    Br J Pharmacol; 2001 Apr; 132(7):1615-23. PubMed ID: 11264257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of 4-amino-5-(3-bromophenyl)-7-(6-morpholino-pyridin-3-yl)pyrido[2,3-d]pyrimidine, an orally active, non-nucleoside adenosine kinase inhibitor.
    Lee CH; Jiang M; Cowart M; Gfesser G; Perner R; Kim KH; Gu YG; Williams M; Jarvis MF; Kowaluk EA; Stewart AO; Bhagwat SS
    J Med Chem; 2001 Jun; 44(13):2133-8. PubMed ID: 11405650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-inflammatory effects of ABT-702, a novel non-nucleoside adenosine kinase inhibitor, in rat adjuvant arthritis.
    Boyle DL; Kowaluk EA; Jarvis MF; Lee CH; Bhagwat SS; Williams M; Firestein GS
    J Pharmacol Exp Ther; 2001 Feb; 296(2):495-500. PubMed ID: 11160636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent developments in the discovery of novel adenosine kinase inhibitors: mechanism of action and therapeutic potential.
    McGaraughty S; Cowart M; Jarvis MF
    CNS Drug Rev; 2001; 7(4):415-32. PubMed ID: 11830758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antinociception by adenosine analogs and inhibitors of adenosine metabolism in an inflammatory thermal hyperalgesia model in the rat.
    Poon A; Sawynok J
    Pain; 1998 Feb; 74(2-3):235-45. PubMed ID: 9520238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific Inhibition of IkappaB kinase reduces hyperalgesia in inflammatory and neuropathic pain models in rats.
    Tegeder I; Niederberger E; Schmidt R; Kunz S; Gühring H; Ritzeler O; Michaelis M; Geisslinger G
    J Neurosci; 2004 Feb; 24(7):1637-45. PubMed ID: 14973242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis, and structure-activity relationship of 6-alkynylpyrimidines as potent adenosine kinase inhibitors.
    Gomtsyan A; Didomenico S; Lee CH; Matulenko MA; Kim K; Kowaluk EA; Wismer CT; Mikusa J; Yu H; Kohlhaas K; Jarvis MF; Bhagwat SS
    J Med Chem; 2002 Aug; 45(17):3639-48. PubMed ID: 12166937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An adenosine kinase inhibitor, ABT-702, inhibits spinal nociceptive transmission by adenosine release via equilibrative nucleoside transporters in rat.
    Otsuguro K; Tomonari Y; Otsuka S; Yamaguchi S; Kon Y; Ito S
    Neuropharmacology; 2015 Oct; 97():160-70. PubMed ID: 26066576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of A-134974, a novel adenosine kinase inhibitor, on carrageenan-induced inflammatory hyperalgesia and locomotor activity in rats: evaluation of the sites of action.
    McGaraughty S; Chu KL; Wismer CT; Mikusa J; Zhu CZ; Cowart M; Kowaluk EA; Jarvis MF
    J Pharmacol Exp Ther; 2001 Feb; 296(2):501-9. PubMed ID: 11160637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonnucleoside inhibitors of adenosine kinase.
    Gomtsyan A; Lee CH
    Curr Pharm Des; 2004; 10(10):1093-103. PubMed ID: 15078144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticonvulsant and antinociceptive actions of novel adenosine kinase inhibitors.
    McGaraughty S; Cowart M; Jarvis MF; Berman RF
    Curr Top Med Chem; 2005; 5(1):43-58. PubMed ID: 15638777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-activity studies of 5-substituted pyridopyrimidines as adenosine kinase inhibitors.
    Cowart M; Lee CH; Gfesser GA; Bayburt EK; Bhagwat SS; Stewart AO; Yu H; Kohlhaas KL; McGaraughty S; Wismer CT; Mikusa J; Zhu C; Alexander KM; Jarvis MF; Kowaluk EA
    Bioorg Med Chem Lett; 2001 Jan; 11(1):83-6. PubMed ID: 11140740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A-740003 [N-(1-{[(cyanoimino)(5-quinolinylamino) methyl]amino}-2,2-dimethylpropyl)-2-(3,4-dimethoxyphenyl)acetamide], a novel and selective P2X7 receptor antagonist, dose-dependently reduces neuropathic pain in the rat.
    Honore P; Donnelly-Roberts D; Namovic MT; Hsieh G; Zhu CZ; Mikusa JP; Hernandez G; Zhong C; Gauvin DM; Chandran P; Harris R; Medrano AP; Carroll W; Marsh K; Sullivan JP; Faltynek CR; Jarvis MF
    J Pharmacol Exp Ther; 2006 Dec; 319(3):1376-85. PubMed ID: 16982702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.